Hancock J F, Hall A
ONYX Pharmaceuticals, Richmond, CA 94806.
EMBO J. 1993 May;12(5):1915-21. doi: 10.1002/j.1460-2075.1993.tb05840.x.
RhoGDI inhibits guanine nucleotide dissociation from post-translationally processed Rho and Rac proteins but its biochemical role in vivo is unknown. We show here that N-terminal effector site mutations in the Rac protein do not compromise its interaction with RhoGDI and that, whilst geranylgeranylation and -AAX proteolysis of the C-terminal CAAX motif of Rac1 and RhoA are required for efficient interaction with RhoGDI, methylesterification of the C-terminal cysteine residue is not required. In vitro, RhoGDI can form stable complexes with Rho and Rac proteins in both the GTP and GDP bound states. Furthermore the Rac-GTP--RhoGDI complex is resistent to the action of recombinant RhoGAP and recombinant BCR. Thus GDI, by complexing with Rac-GTP and preventing GAP stimulated GTP hydrolysis, may allow transit of the activated form of the Rac protein between physically separated activator and effector proteins in the cell.
Rho鸟苷酸解离抑制蛋白(RhoGDI)可抑制鸟嘌呤核苷酸从翻译后加工的Rho和Rac蛋白上解离,但它在体内的生化作用尚不清楚。我们在此表明,Rac蛋白的N端效应位点突变并不影响其与RhoGDI的相互作用,并且,虽然Rac1和RhoA的C端CAAX基序的香叶基香叶基化和-AAX蛋白酶解是与RhoGDI有效相互作用所必需的,但C端半胱氨酸残基的甲基酯化并非必需。在体外,RhoGDI在GTP和GDP结合状态下均可与Rho和Rac蛋白形成稳定复合物。此外,Rac-GTP-RhoGDI复合物对重组RhoGAP和重组BCR的作用具有抗性。因此,GDI通过与Rac-GTP复合并防止GAP刺激的GTP水解,可能允许Rac蛋白的活化形式在细胞内物理分离的激活蛋白和效应蛋白之间转运。